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Abstract 
Background: Warfarin is widely used for the prevention and treatment of cardiac, thromboembolic and hypercoagu-
lable diseases. Since warfarin is a narrow therapeutic index medicine, it requires close monitoring when used in the 
outpatient setting and on long term basis. Warfarin has been found to be associated with a number of complications 
especially bleeding. Patients’ knowledge on warfarin can improve anticoagulation control with decrease in adverse 
drug reaction and other associated complications. The objective was to assess knowledge level of warfarin therapy 
among its users and to provide adequate education and counseling to the patients.
Methods: In the present cross sectional study, 34 patients on warfarin were interviewed. Patients’ knowledge on 
warfarin was assessed using a validated Anticoagulation Knowledge Assessment (AKA) questionnaire comprising 
29 questions. Each correct answer scored 3.45 points whereas an incorrect answer scored zero point. Patient who 
answered at least 21 questions correctly or scored (21 × 3.45 = 72.4 %) was considered to have adequate level 
of knowledge or have obtained a passing score. Association between independent variables and AKA score was 
assessed using Pearson Chi square test or Fisher’s exact test for categorical variables. Patients were counseled regard-
ing proper warfarin use by the researcher pharmacists at the end of each data collection schedule.
Results: Of the 34 patients, only 5.8 % (n = 2) achieved a passing score whereas 94.1 % (n = 32) failed to achieve the 
passing score. 67.6 % of the patients (n = 23) achieved a score below 50 %. More than 50 % of the patients incorrectly 
answered 15 questions in the questionnaire. None of the patients scored 100 %. No significant association was found 
between age, gender of patients and total warfarin score. A significant association (p < 0.05) was found between 
duration of warfarin therapy and total warfarin score.
Conclusions: Warfarin knowledge was poor among the patients. Hence, regular counseling with timely assessment 
of their understanding was felt necessary.
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Background
Warfarin is the preferred oral anticoagulant in conditions 
requiring prolonged anticoagulation [1–4]. It is widely 
used for the prevention and treatment of cardiac, throm-
boembolic and hypercoagulable diseases [1, 2, 5–8]. 
Since warfarin is a narrow therapeutic index medicine, 
it requires close monitoring when used in the outpatient 
setting and on long term basis [2, 3, 5, 9]. Warfarin has 
been found to be associated with a number of compli-
cations especially bleeding [10, 11]. Moreover, among 
the list of prescription medications it has been listed as 
a highly interacting drug with food and other medica-
tions [2, 11] and consequently improper control over 
anticoagulation can either result into compromised drug 
efficacy or increased risk of haemorrhage [2, 11–13]. 
Hence, monitoring of the International Normalized Ratio 
(INR) of the patients on warfarin becomes very essential 
to create a balance between its anticoagulation efficacy 
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and possible bleeding complications [4, 5]. Knowledge 
of warfarin’s action, its potential side effects, interacting 
drugs and food, cautions to be taken and significance of 
adherence to warfarin plays an important role in achiev-
ing the desired therapeutic outcome while preventing the 
adverse reactions [2, 13, 14].
Providing adequate education on warfarin with the aim 
of improving patients’ knowledge can be a useful strategy 
to decrease the possible adverse drug reactions and other 
associated complications. Proper knowledge on warfarin 
can also help patients attain a more stable anticoagula-
tion control thus decreasing the frequency of INR checks 
and hospitalizations [3, 8, 15, 16]. A deficit in knowledge 
among patients taking warfarin has been shown espe-
cially in elderly which could be one of the important fac-
tors determining the degree of anticoagulation control 
[3, 4, 13, 15]. This makes it important to assess level of 
knowledge of warfarin therapy among its user and pro-
vide adequate education and counselling to the patients 
[1–4, 13, 15].
To date, none of the studies have assessed the knowl-
edge level among warfarin users in Nepal. Realizing the 
need to fulfil this gap we conducted this study with the 
aim of determining the knowledge level among patients 




This was a quantitative, cross sectional, single center 
study conducted over a period of 8  months in Shahid 
Gangalal National Heart Centre, Nepal. The major indi-
cations for warfarin therapy among the patients selected 
for the study were: Atrial fibrillation (AF), Deep vein 
thrombosis (DVT), Atrial fibrillation with valve replace-
ment and Mitral stenosis with Atrial fibrillation. Tar-
get INR for most indications of warfarin was 2.5 (range 
2.0–3.0).
Study procedure
Patients above 18 years who visited the outpatient phar-
macy and had been taking warfarin for at least 2 months 
were interviewed from August 2013 to March 2014. 
Patients who refused to participate in the study were 
excluded. A face to face interview was carried out using 
a pre-validated Anticoagulation Knowledge Assess-
ment (AKA) questionnaire [16, 17]. Each question and 
its options were read to the patients by the researcher 
and the patient had to choose one among the four given 
options. Demographic information such as patients’ age, 
gender and other clinically relevant information such 
as duration of warfarin therapy and preferred source 
of counseling was also collected. A total of 34 patients 
were interviewed. After completion of the interview the 
patients were told the correct answer for each of the 29 
questions in the questionnaire. Further counseling on 
warfarin therapy was also done.
Ethical consideration
Shahid Gangalal National Heart Centre granted permis-
sion for the study to be conducted and approved ethically.
Data collection instrument
The AKA questionnaire is a validated instrument 
designed to assess the patients’ anticoagulation knowl-
edge [16, 17]. It comprises of 29 multiple choice ques-
tions. Each correct answer scored 3.45 points whereas 
an incorrect answer scored zero point. Patient who 
answered at least 21 questions correctly or scored 
(21 ×  3.45 =  72.4  %) was considered to have adequate 
level of knowledge or have obtained a passing score [17].
Statistical analysis
Anticoagulation knowledge level was determined based 
on total AKA questionnaire score and number of the 
questions answered correctly. Data were analyzed via sta-
tistical package for the social sciences (SPSS) version 22. 
Associations between the independent variables and the 
AKA score was assessed using Pearson Chi square test 
or Fisher’s exact test (when the individual cell frequency 
is less than 5) for categorical variables, considering the 
power of the study to be 80 % while selecting the sample 
size by applying simple random sampling technique.
Results
Of the 34 patients enrolled in the study, the mean age was 
60 ± 14.6. Of the study population 55.9 % was male. Most 
of the patients had been on warfarin therapy for less than 
1 year (n = 19; 55.8 %) whereas 44.1 % of the study popu-
lation (n = 15) were receiving warfarin therapy for more 
than 1  year. When inquired about the preferred source 
of counseling 91.1  % (n  =  31) of the study population 
wished to receive counseling on warfarin therapy from 
the doctors whereas only 8.8 % (n = 3) preferred pharma-
cists as the counselors. Demographic data are presented 
in Table 1.
Of the 34 patients only 5.8 % (n = 2) achieved a pass-
ing score or were able to answer at least 21 questions 
correctly whereas majority of the study population i.e., 
94.1 % (n = 32) failed to achieve the passing score. 67.6 % 
of the patients (n  =  23) achieved a score below 50  %. 
Out of the 29 questions 15 questions were incorrectly 
answered by more than 50 % of the patients. None of the 
patients were able to score 100 %. Percentage of patients 
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incorrectly answering the questions was presented in 
Table 2.
No significant association was found between the age, 
gender of the patients and the total warfarin score, con-
sidering the power of the study to be 80 %. A significant 
association (p  <  0.05) was found between duration of 
warfarin therapy and the total warfarin score.
Discussions
Of the total study population 94.1 % was found to have 
inadequate knowledge on their warfarin therapy. This fig-
ure was found to be higher than the findings by Hu et al. 
(n = 100, 61 %), Baker et al. (n = 185, 74.1 %) and Nasser 
et  al. [4, 17, 18]. This indicated poor knowledge level 
among the study population which might be either due to 
lack of proper understanding among the patients or due 
to lack of adequate and repetitive counselling.
Lowest score was obtained for patients’ knowledge on 
how long warfarin should have been taken once started 
and the drinks that could decrease the effectiveness of 
warfarin. This was in contrast to the findings of Khudair 
et al. who found the least level of knowledge was on war-
farin drug interactions, effect of a missing dose and its 
management and whether or not healthcare professionals 
should have been informed on their current therapy [5].
Majority of the study population preferred physicians 
as their preferred counsellor on warfarin therapy (n = 31, 
91.1 %). Similar findings have been reported by Khudair 
et  al. who reported 57  % of the patients (n  =  80) pre-
ferred physicians as their warfarin counsellor [5].
On average, 58  % of the study population were una-
ware of the interaction of warfarin with food while 
48.3 % of the patients were unaware of the need of con-
sulting the healthcare professionals prior to taking other 
medications. The review study by Nasser et al. had simi-
lar findings where 60–80 % of the patients were unaware 
of the drug/food interactions with warfarin [4]. Of the 
study population 44.1  % of the patients were unaware 
of the interaction of alcohol with warfarin. This finding 
was consistent with the result obtained by Roche et  al. 
and another study by Yahaya et al. where 22–49 % of the 
patients and 34.6 % of the study population respectively 
were unaware of the interaction of alcohol and warfarin 
[2, 3]. In regard to the need of avoidance of non-steroidal 
anti-inflammatory drugs, 44.1 % of the study population 
lacked proper understanding similar to the findings in 
the survey by Campbell and in a study by Roche where 
27 % of the patients were unaware of the need to avoid 
aspirin [3, 14].
Table 1 Characteristics of study population
Characteristics Frequency (%)
Gender
 Male 19 (55.8)
 Female 15 (44.1)
Age group
 18–38 5 (14.7)
 39–59 7 (20.5)
 60–80 22 (64.7)
Preferred counselor
 Physicians 31 (91.1)
 Pharmacists 3 (8.8)
Warfarin therapy duration
 2–12 months 19 (55.8)
 >1 year 15 (44.1)
Table 2 Response to questions
Questions Incorrect answer 
(percentage)
Non-steroidal drug choice 44.1
Food warfarin interaction 76.4
Warfarin effect leading to emergency unit 58.8
Managing missed dose 55.8
Spinach intake frequency 70.5
Interaction with alcohol 73.5
Action to take when buying multivitamin 23.5
Action to take when you run out of prescription 29.4
Most likely side effect of warfarin 67.6
Action to take when buying cold medication 61.7
Action to take when taking dental appointment 23.5
Action to take when taking antibiotic 58.8
Action of warfarin 79.4
Best time to take warfarin 14.7
Effect seen when INR is high 41.1
Drink decreasing warfarin effectiveness 94.1
Situation where visiting emergency is essential 61.7
Action in taking herbal supplements 67.6
Frequency of PT/INR test 44.1
PT/INR test result indicates 44.1
Side effect to be informed to Coumadin clinic 70.5
Test to be carried out routinely 50
Interaction of over-the-counter drugs with warfarin 47
Warfarin effect requiring emergency unit visit 44.1
warfarin food interaction 26.4
Action to take if you have both generic and brand 
of warfarin
44.1
Time warfarin stays in body system 82.3
Length of time warfarin needs to be taken 94.1
Most risky activity to avoid while on warfarin 32.3
Page 4 of 5Shrestha et al. BMC Res Notes  (2015) 8:429 
In our study no association was found between age and 
knowledge score of the patients, considering the power of 
the study to be 80 %. The findings were in contrary to the 
findings in studies where age was found to have negative 
effect on total knowledge score of the patients [4, 15, 18, 
19]. Similarly, no association was found between gender 
and the total knowledge score which was supported by 
previous studies [2, 5, 15, 18]. Knowledge was related to 
duration of therapy. Similar findings were presented by 
Tang et  al. but the finding was in contrast to the result 
obtained by Hasan et al. where no association was found 
between duration of therapy and knowledge [10, 15].
In a study by Imran F. Khudair in Hamad General Hos-
pital, Doha, the author reported Physicians to be the 
main educators who may not have sufficient time to pro-
vide proper counseling. Also, the author reported that 
most patients preferred to receive counseling on warfa-
rin from the physicians followed by pharmacists and then 
the nurses. In our study we wanted to know the concept 
of the general public as to whom they perceive as the 
main educator on warfarin.
Study limitation
Altogether 175 patients were asked to participate in the 
study, out of which only 34 patients (19.43 %) agreed for 
participation. Sample size was small to generalize the 
study. Large scale and multi-centric study would be man-
datory to generalize the study findings, for which this 
study could become a pathfinder in a resource constraint 
country like Nepal.
Conclusions
The findings of this study show that majority of the 
patients have poor level of knowledge on warfarin. Age 
and gender of the patients were found to have no cor-
relation with the knowledge score whereas a significant 
association was found between duration of warfarin 
therapy and the total knowledge score. Patients should 
have proper knowledge on the adverse effects, mecha-
nism of action, dietary and drug interactions of warfa-
rin and actions to be taken if adverse effects are seen 
or in case of missed dose. The gap in knowledge level 
of patients can be filled by providing education to the 
patients and the healthcare providers play an important 
role in it.
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